The role of butyrate in the reverse transformation reaction in mammalian cells

J Cell Physiol. 1978 Jan;94(1):69-75. doi: 10.1002/jcp.1040940109.

Abstract

The reverse transformation reaction of Chinese hamster ovary cells from compact, epithelial-like, randomly growing, heavily knobbed, lectin reactive cells into stretched, tighly adherent, smooth-surfaced, lectin resistant, fibroblast-like cells normally elicited by dibutyryl cAMP can be produced to its complete extent by N6-monobutyryl cAMP or 8-bromo-cAMP, O2'-monobutyryl cAMP is ineffective as is cAMP itself in the absence of an inhibitor of phosphodiesterase activity. In the presence of a phosphodiesterase inhibitor, cAMP is fully effective. These results indicate that the role of the butyryl groups of dibutyryl cAMP and, especially, the N6-butyryl, in the reverse transformation reaction is protection of the cAMP analogue from degradation. Butyrate at concentrations of about 1 mM does produce a response which to some extent mimics that of cAMP analogues. The cells, however, fail to assume a fibroblastic-like shape, but rather become flattened. The butyrate effect is much slower and less readily reversible than that evoked by cAMP analogues. Butyrate produces an approximately 2-fold increase in intracellular cAMP levels. These results are consistent with the hypothesis that butyrate effects, in part, are mediated by AMP.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Butyrates / pharmacology*
  • Cell Line
  • Cell Transformation, Neoplastic / drug effects*
  • Concanavalin A / pharmacology
  • Cyclic AMP / analogs & derivatives
  • Cyclic AMP / metabolism
  • Cyclic AMP / pharmacology
  • Testolactone / pharmacology
  • Theophylline / pharmacology

Substances

  • Butyrates
  • Concanavalin A
  • Testolactone
  • Theophylline
  • Cyclic AMP